Form 8-K - Current report:
SEC Accession No. 0001453687-25-000050
Filing Date
2025-01-27
Accepted
2025-01-27 07:04:17
Documents
15
Period of Report
2025-01-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rnac-20250127.htm   iXBRL 8-K 30210
2 EX-99.1 pressrelease012725.htm EX-99.1 15039
6 cartesian_logoxcolorxcmyk.jpg GRAPHIC 1268513
  Complete submission text file 0001453687-25-000050.txt   1850609

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnac-20250127.xsd EX-101.SCH 1862
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnac-20250127_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnac-20250127_pre.xml EX-101.PRE 12572
17 EXTRACTED XBRL INSTANCE DOCUMENT rnac-20250127_htm.xml XML 2722
Mailing Address 7495 NEW HORIZON WAY FREDERICK MD 21703
Business Address 7495 NEW HORIZON WAY FREDERICK MD 21703 301-348-8698
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 25555744
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)